(Q36341748)

13 August 2017

1 reference

title

Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy (English)

1 reference

ORCID Public Data File 2021

13 August 2017

1 reference

author name string

Thomas N Ferraro

series ordinal

1

1 reference

13 August 2017

Dennis J Dlugos

series ordinal

2

1 reference

13 August 2017

Russell J Buono

series ordinal

3

1 reference

13 August 2017

language of work or name

1 reference

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

89-103

1 reference

The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

The neurobiology of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Recent developments from genetic mouse models of seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Genetic polymorphisms and functional characterization of the 5'-flanking region of the human CYP2C9 gene: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Potential role of drug transporters in the pathogenesis of medically intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Genetic association studies in epilepsy: "the truth is out there".

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Interaction of antiepileptic drugs with human P-glycoprotein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

RLIP76, a non-ABC transporter, and drug resistance in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Guidelines for Epidemiologic Studies on Epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Idiopathic generalized epilepsy with generalized and other seizures in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Familial clustering of seizure types within the idiopathic generalized epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Newly Diagnosed Epilepsy in Children: Presentation at Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

The early identification of candidates for epilepsy surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Predicting outcome of initial treatment with carbamazepine in childhood focal epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Antiepileptic drug monotherapy: pediatric concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Misdiagnosis and treatment in juvenile myoclonic epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Epileptic syndromes in childhood: clinical features, outcomes, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Priorities and standards in pharmacogenetic research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Association of genetic loci: replication or not, that is the question

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Issues in association analysis: error control in case-control association studies for disease gene discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Genetic dissection of diseases: design and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Clinical pharmacokinetics of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

Analysis of single-locus tests to detect gene/disease associations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.1.89

21 January 2018

Identifiers

DOI

10.2217/14622416.7.1.89

1 reference

13 August 2017

1 reference